XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Capital in Excess of Par [Member]
Treasury Stock [Member]
Retained Earnings (Accumulated Deficit) [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Parent [Member]
Noncontrolling Interest [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Capital in Excess of Par [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Treasury Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Retained Earnings (Accumulated Deficit) [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Parent [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Noncontrolling Interest [Member]
Balance at Dec. 31, 2021 $ 355,828 $ 281 $ 280,038 $ (24,919) $ 30,606 $ 1,034 $ 287,040 $ 68,788                
Balance, shares at Dec. 31, 2021   28,124,629   (2,951,243)                        
Net income 11,353       9,841   9,841 1,512                
Distributions to non-controlling interest (1,512)             (1,512)                
Stock-based compensation expense 598 $ 4 594       598                  
Issuance of restricted stock, net, shares   383,925                            
Forfeiture of restricted stock, net, shares   (5,730)                            
Exercise of stock options, value 152   152       152                  
Exercise of stock options, shares   23,192                            
Purchase of common stock (in Shares)       (67,660)                        
Purchase of common stock (617)     $ (617)     (617)                  
Dividend paid on common stock (2,044)       (2,044)   (2,044)                  
Other comprehensive loss, net of tax (1,717)         (1,717) (1,717)                  
Ending balance at Mar. 31, 2022 362,041 $ 285 280,784 $ (25,536) 38,403 (683) 293,253 68,788                
Ending balance, shares at Mar. 31, 2022   28,526,016   (3,018,903)                        
Balance at Dec. 31, 2021 355,828 $ 281 280,038 $ (24,919) 30,606 1,034 287,040 68,788                
Balance, shares at Dec. 31, 2021   28,124,629   (2,951,243)                        
Net income 26,165                              
Other comprehensive loss, net of tax (3,135)                              
Ending balance at Jun. 30, 2022 362,841 $ 285 281,647 $ (35,510) 49,732 (2,101) 294,053 68,788                
Ending balance, shares at Jun. 30, 2022   28,530,373   (4,291,053)                        
Balance at Dec. 31, 2021 $ 355,828 $ 281 280,038 $ (24,919) 30,606 1,034 287,040 68,788                
Balance, shares at Dec. 31, 2021   28,124,629   (2,951,243)                        
Exercise of stock options, shares 23,745                              
Net change in unrealized gains on investments, net of tax $ (4,400)                              
Ending balance at Dec. 31, 2022 370,524 $ 287 283,663 $ (45,538) 66,673 (3,349) 301,736 68,788 $ 360,589 $ 287 $ 283,663 $ (45,538) $ 56,738 $ (3,349) $ 291,801 $ 68,788
Ending balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022 $ (9,935)       (9,935)   (9,935)                  
Ending balance, shares at Dec. 31, 2022 23,061,673 28,663,827   (5,602,154)           28,663,827   (5,602,154)        
Balance at Mar. 31, 2022 $ 362,041 $ 285 280,784 $ (25,536) 38,403 (683) 293,253 68,788                
Balance, shares at Mar. 31, 2022   28,526,016   (3,018,903)                        
Net income 14,811       13,300   13,300 1,511                
Distributions to non-controlling interest (1,511)             (1,511)                
Stock-based compensation expense 863   863       863                  
Forfeiture of restricted stock, net, shares   587                            
Issuance in connection with vesting of restricted stock units   4,944                            
Purchase of common stock (in Shares)       1,272,150                        
Purchase of common stock (9,974)     $ 9,974     (9,974)                  
Dividend paid on common stock (1,971)       1,971   (1,971)                  
Other comprehensive loss, net of tax (1,418)         (1,418) (1,418)                  
Ending balance at Jun. 30, 2022 362,841 $ 285 281,647 $ (35,510) 49,732 (2,101) 294,053 68,788                
Ending balance, shares at Jun. 30, 2022   28,530,373   (4,291,053)                        
Balance at Dec. 31, 2022 $ 370,524 $ 287 283,663 $ (45,538) 66,673 (3,349) 301,736 68,788 360,589 $ 287 283,663 $ (45,538) 56,738 (3,349) 291,801 68,788
Balance, shares at Dec. 31, 2022 23,061,673 28,663,827   (5,602,154)           28,663,827   (5,602,154)        
Net income $ 16,873       15,361   15,361 1,512                
Distributions to non-controlling interest (1,512)             (1,512)                
Stock-based compensation expense 1,036 $ 2 1,034       1,036                  
Issuance of restricted stock, net, shares   304,749                            
Withheld restricted stock for employees' tax obligations, shares   (91,169)                            
Withheld restricted stock for employees' tax obligations, value (768)   (768)       (768)                  
Forfeiture of restricted stock, net, shares   (9,843)                            
Exercise of stock options, value $ 292   292       292                  
Exercise of stock options, shares 44,583 [1] 44,583                            
Dividend paid on common stock $ (1,863)       (1,863)   (1,863)                  
Net change in unrealized gains on investments, net of tax 506         506 506                  
Ending balance at Mar. 31, 2023 375,153 $ 289 284,221 $ (45,538) 70,236 (2,843) 306,365 68,788                
Ending balance, shares at Mar. 31, 2023   28,912,147   (5,602,154)                        
Balance at Dec. 31, 2022 370,524 $ 287 283,663 $ (45,538) 66,673 (3,349) 301,736 68,788 $ 360,589 $ 287 $ 283,663 $ (45,538) $ 56,738 $ (3,349) $ 291,801 $ 68,788
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022 $ (9,935)       (9,935)   (9,935)                  
Balance, shares at Dec. 31, 2022 23,061,673 28,663,827   (5,602,154)           28,663,827   (5,602,154)        
Net income $ 32,555                              
Other comprehensive loss, net of tax (400)                              
Net change in unrealized gains on investments, net of tax 400                              
Ending balance at Jun. 30, 2023 $ 387,764 $ 289 285,435 $ (45,538) 82,539 (3,749) 318,976 68,788                
Ending balance, shares at Jun. 30, 2023 23,345,017 28,947,171   (5,602,154)                        
Balance at Mar. 31, 2023 $ 375,153 $ 289 284,221 $ (45,538) 70,236 (2,843) 306,365 68,788                
Balance, shares at Mar. 31, 2023   28,912,147   (5,602,154)                        
Net income 15,682       14,170   14,170 1,512                
Distributions to non-controlling interest (1,512)             (1,512)                
Stock-based compensation expense $ 1,214 $ 0 1,214       1,214                  
Issuance of restricted stock, net, shares   11,734                            
Forfeiture of restricted stock, net, shares   (204)                            
Issuance in connection with vesting of restricted stock units   23,211                            
Exercise of stock options, shares 283 [1] 283                            
Dividend paid on common stock $ (1,867)       (1,867)   (1,867)                  
Other comprehensive loss, net of tax (906)         (906) (906)                  
Net change in unrealized gains on investments, net of tax 900                              
Ending balance at Jun. 30, 2023 $ 387,764 $ 289 $ 285,435 $ (45,538) $ 82,539 $ (3,749) $ 318,976 $ 68,788                
Ending balance, shares at Jun. 30, 2023 23,345,017 28,947,171   (5,602,154)                        
[1] The aggregate intrinsic value of exercised options, which represents the difference between the price of the Company’s common stock at the exercise date and the related exercise price of the underlying options, was less than $0.1 million for the three and six months ended June 30, 2023 and was $0.1 million for the year ended December 31, 2022.